Hipersensibilidad a Betalactámicos. Dra Yurlany Gutiérrez (20 de septiembre 2018)

De


Hipersensibilidad a Betalactámicos.  Dra Yurlany Gutiérrez (20 de septiembre 2018)

Comentarios

  1. Ricardo Cardona Villa21 de septiembre de 2018 a las 9:39

    Artículo recomendado:

    Cross-reactivity in b-Lactam Allergy
    Robert J. Zagursky, PhD, and Michael E. Pichichero, MD Rochester, NY

    b-Lactam drugs (penicillins, amoxicillin, and cephalosporins)
    account for 42.6% of all severe drug-induced anaphylaxis. In this
    review, we focus on clinically significant immunologic crossreactivity
    in patients with confirmed penicillin allergy to
    cephalosporins, and the structural involvement of the R1 and R2
    chemical side chains of the cephalosporins causing IgE-mediated
    cross-reactivity with penicillin and other cephalosporins. Skin
    tests predict IgE-mediated reactions and showed cross-reactivity
    between penicillins and early generation cephalosporins that
    shared side chains, but confirmatory challenge data are lacking.
    Later-generation cephalosporins, which have distinct side chains,
    do not have any skin test cross-reactivity with penicillin/
    amoxicillin. There is debate as to the involvement of R2 side
    chains as the antigenic determinants that cause IgE-mediated
    hypersensitivity with various cephalosporins. Avoidance of
    cephalosporins, when they are the drug of choice in a penicillinallergic individual, results in significant morbidity that outweighs the low risk of anaphylaxis. We conclude that there is ample evidence to allow the safe use of cephalosporins in patients with isolated confirmed penicillin or amoxicillinallergy.

    Texto completo:
    http://dx.doi.org/10.1016/j.jaip.2017.08.027

    ResponderEliminar

Publicar un comentario

Entradas populares de este blog

Future perspectives of anticholinergics for the treatment of asthma in adults and children. Viernes 4 de octubre

De
Future perspectives of anticholinergics for the treatment of asthma in adults and children. Authors : Buhl R1, Hamelmann E2,3. 1 Pulmonary Department, Johannes Gutenberg University Hospital Mainz, Mainz, Germany, roland.buhl@unimedizin-mainz.de. 2 Children's Center Bethel, Evangelic Hospital Bethel, Department of Pediatrics, Bielefeld, Germany. 3 University Children's Hospital, Allergy Center Ruhr, Ruhr University Bochum, Bochum, Germany. Abstract Despite major advances in therapeutic interventions and the availability of detailed treatment guidelines, a high proportion of patients with symptomatic asthma remain uncontrolled. Asthma management is largely guided by the Global Initiative for Asthma (GINA) strategy and is based on a backbone of inhaled corticosteroid (ICS) therapy with the use of additional therapies to achieve disease control. Inhaled long-acting bronchodilators alone and in combination are the preferred add-on treatment options. Although long-ac...
Leer más

ICON: Diagnosis and management of allergic conjunctivitis. Miércoles 25 de marzo

De
ICON: Diagnosis and management of allergic conjunctivitis. Authors: Bielory L1, Delgado L2, Katelaris CH3, Leonardi A4, Rosario N5, Vichyanoud P6. Author information Abstract Ocular allergy (OA), interchangeably known as allergic conjunctivitis, is a common immunological hypersensitivity disorder affecting up to 40% of the population. Ocular allergy has been increasing in frequency, with symptoms of itching, redness, and swelling that significantly impacts an individual's quality of life (QOL). Ocular allergy is an often underdiagnosed and undertreated health problem, because only 10% of patients with OA symptoms seek medical attention, whereas most patients manage with over-the-counter medications and complementary nonpharmacological remedies. The clinical course, duration, severity, and co-morbidities are varied and depend, in part, on the specific ocular tissues that are affected and on immunologic mechanism(s) involved, both local and systemic. It is frequently associat...
Leer más

Multiple Drug Hypersensitivity Syndrome in a Large Database. Lunes 16 de marzo

De
Multiple Drug Hypersensitivity Syndrome in a Large Database Authors: Quentin Landry  1 , Shuchen Zhang  2 , Laetitia Ferrando  1 , Jean Luc Bourrain  1 , Pascal Demoly  3 , Anca-Mirela Chiriac  4 Abstract Background: Multiple drug hypersensitivity syndrome (MDHS) is defined as confirmed drug hypersensitivity (DH) to at least 2 chemically and pharmacologically unrelated drugs. Reports of MDHS are scarce and poorly specified, and studies that diagnose MDHS on the basis of positive allergy test results are lacking. Objective: To evaluate retrospectively the frequency and characteristics of patients with MDHS in a large database. Methods: We included all patients who consulted and were tested in our Allergy Unit between September 1996 and February 2018 for a suspicion of DH. Clinical history and allergy workup results compiled in our Drug Allergy and Hypersensitivity Database were reviewed, and data of patients with a diagnosis of MDHS were retriev...
Leer más